GGrantIndex
Sort

48,018 grants matching immunotherapy

RIG-I Activating Nanoparticles for Immunopotentiation

$597,471
John Tanner Wilson · Vanderbilt University · R01 · FY2025 · EB

Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

$597,298
Farrokh Dehdashti · Washington University · R01 · FY2021 · CA

Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers

$597,289
Isabelle Bedrosian · University Of Tx Md Anderson Can Ctr · UG3 · FY2025 · CA

Transformative personalized vascular disrupting cancer immunotherapy

$597,229
George Coukos · University Of Pennsylvania · R01 · FY2012 · CA

Tumor selective inhibition of the WNT pathway

$597,189
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Targeting B7-H3 in ovarian cancer

$597,170
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)

$597,082
Noah M Hahn · Johns Hopkins University · R01 · FY2023 · CA

Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities

$597,046
Mark P Rubinstein · Ohio State University · R01 · FY2024 · CA

Vaccine and immunotherapy strategies for cancer and viruses causing cancer

$596,948
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA

Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy

$596,869
T.-C. Wu · Johns Hopkins University · R01 · FY2019 · CA

Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma

$596,833
Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Optimizing Syngeneic Mouse Models to Target Mutant p53

$596,803
Yong Li · Baylor College Of Medicine · R01 · FY2023 · CA

Optimizing Syngeneic Mouse Models to Target Mutant p53

$596,803
Yong Li · Baylor College Of Medicine · R01 · FY2025 · CA

Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC

$596,748
Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

Chemo-radio immunotherapy for pediatric brain tumors

$596,748
David H Munn · Augusta University · R01 · FY2019 · CA

Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer

$596,742
Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Career Development in Pediatric and Medical Oncology

$596,700
Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2013 · CA

Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer

$596,634
Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2024 · CA

Outcomes for CLL patients treated with novel therapy

$596,539
Neil E Kay · Mayo Clinic Rochester · R01 · FY2024 · CA

MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma

$596,467
Dara L Kraitchman · Johns Hopkins University · R01 · FY2024 · CA

(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer

$596,436
Brinda Emu · Yale University · R01 · FY2019 · CA

The Role of the Tumor Suppressor ARID1A in R loop Homeostasis and Tumor Immunity

$596,336
Diana Clare Hargreaves · Salk Institute For Biological Studies · R01 · FY2024 · CA

Preclinical and Clinical Models of Drug Induced Kidney Injury

$596,308
Melanie S Joy · University Of Colorado Denver · R01 · FY2024 · CA

Project 1: Co-stimulation and Regulation of Anti-viral Immunity

$596,255
Arlene H Sharpe · Harvard Medical School · P01 · FY2019 · AI

Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays

$596,244
Stephen R. Bowen · University Of Washington · R01 · FY2023 · CA